Covidien has introduced the HALO60 ablation catheter for the endoscopic treatment of Barrett's esophagus.
The HALO60 ablation catheter can be used alone or in combination with the available HALO90 ablation catheter and HALO360+ ablation catheter, a balloon-based endoscopic ablation system to treat larger, circumferential areas of Barrett’s esophagus.
HALO60 catheter features a small electrode mounted on the end of an endoscope which has approximately 60% of the surface area of the larger HALO90 focal device.
All HALO products utilize patented technology that controls the amount of energy delivered to the tissue to safely and effectively remove the diseased tissue and facilitate the re-growth of new and healthy tissue.
The HALO product line joined the Covidien’s portfolio when the company has purchased Barrx Medical.
Barrx Medical global marketing vice president Robert Haggerty said comments such as easier to intubate patients and improved maneuverability and especially nice for patients with narrow esophagi are reinforcing the value of the company’s product and how it will fit into the HALO toolkit.
"We also have received a positive response from physicians who treat bleeding conditions such as gastric antral vascular ectasia and radiation proctitis," Haggerty added.